Citadel Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Buy |
307,100
+83,300
| +37% | +$2.48M | ﹤0.01% | 3228 |
|
|
2025
Q4 | $6.67M | Sell |
223,800
-102,000
| -31% | -$3.33M | ﹤0.01% | 3847 |
|
|
2025
Q3 | $11.8M | Sell |
325,800
-170,300
| -34% | -$5.61M | ﹤0.01% | 3023 |
|
|
2025
Q2 | $17.9M | Sell |
496,100
-59,500
| -11% | -$2.22M | ﹤0.01% | 2282 |
|
|
2025
Q1 | $21.9M | Buy |
555,600
+230,700
| +71% | +$7.76M | ﹤0.01% | 1941 |
|
|
2024
Q4 | $9.78M | Sell |
324,900
-1,800
| -0.6% | -$51.7K | ﹤0.01% | 3015 |
|
|
2024
Q3 | $7.64M | Buy |
326,700
+141,100
| +76% | +$3.08M | ﹤0.01% | 3307 |
|
|
2024
Q2 | $3.3M | Sell |
185,600
-35,100
| -16% | -$560K | ﹤0.01% | 4413 |
|
|
2024
Q1 | $3.36M | Sell |
220,700
-140,800
| -39% | -$2.24M | ﹤0.01% | 4598 |
|
|
2023
Q4 | $6.17M | Buy |
361,500
+70,400
| +24% | +$818K | ﹤0.01% | 3508 |
|
|
2023
Q3 | $2.43M | Sell |
291,100
-385,000
| -57% | -$5.37M | ﹤0.01% | 4866 |
|
|
2023
Q2 | $16.8M | Buy |
676,100
+225,100
| +50% | +$5.81M | ﹤0.01% | 2063 |
|
|
2023
Q1 | $6.78M | Sell |
451,000
-495,500
| -52% | -$7.53M | ﹤0.01% | 3324 |
|
|
2022
Q4 | $11.2M | Buy |
946,500
+55,300
| +6% | +$401K | ﹤0.01% | 2669 |
|
|
2022
Q3 | $5.28M | Buy |
891,200
+144,300
| +19% | +$946K | ﹤0.01% | 3770 |
|
|
2022
Q2 | $3.17M | Buy |
746,900
+71,800
| +11% | +$448K | ﹤0.01% | 4657 |
|
|
2022
Q1 | $6.42M | Buy |
675,100
+250,300
| +59% | +$2.9M | ﹤0.01% | 3703 |
|
|
2021
Q4 | $8.07M | Buy |
424,800
+83,700
| +25% | +$2.17M | ﹤0.01% | 3434 |
|
|
2021
Q3 | $11.4M | Buy |
341,100
+137,900
| +68% | +$4.27M | ﹤0.01% | 2847 |
|
|
2021
Q2 | $7.88M | Sell |
203,200
-28,000
| -12% | -$1.1M | ﹤0.01% | 3526 |
|
|
2021
Q1 | $11.1M | Sell |
231,200
-121,700
| -34% | -$5.85M | ﹤0.01% | 2818 |
|
|
2020
Q4 | $18.4M | Buy |
352,900
+37,600
| +12% | +$1.27M | ﹤0.01% | 1899 |
|
|
2020
Q3 | $8.44M | Buy |
315,300
+82,600
| +35% | +$1.9M | ﹤0.01% | 2490 |
|
|
2020
Q2 | $4.53M | Sell |
232,700
-148,600
| -39% | -$2.39M | ﹤0.01% | 3220 |
|
|
2020
Q1 | $3.75M | Buy |
381,300
+163,900
| +75% | +$2.07M | ﹤0.01% | 3123 |
|
|
2019
Q4 | $2.41M | Buy |
217,400
+23,300
| +12% | +$177K | ﹤0.01% | 4108 |
|
|
2019
Q3 | $1.09M | Sell |
194,100
-34,000
| -15% | -$237K | ﹤0.01% | 5449 |
|
|
2019
Q2 | $1.97M | Buy |
228,100
+61,500
| +37% | +$465K | ﹤0.01% | 4531 |
|
|
2019
Q1 | $1.34M | Sell |
166,600
-212,200
| -56% | -$1.15M | ﹤0.01% | 5088 |
|
|
2018
Q4 | $1.55M | Sell |
378,800
-42,000
| -10% | -$209K | ﹤0.01% | 4569 |
|
|
2018
Q3 | $2.36M | Buy |
420,800
+204,300
| +94% | +$2.33M | ﹤0.01% | 4131 |
|
|
2018
Q2 | $2.85M | Buy |
216,500
+52,400
| +32% | +$721K | ﹤0.01% | 3563 |
|
|
2018
Q1 | $2.33M | Buy |
164,100
+28,100
| +21% | +$359K | ﹤0.01% | 3498 |
|
|
2017
Q4 | $1.11M | Buy |
136,000
+39,400
| +41% | +$344K | ﹤0.01% | 4509 |
|
|
2017
Q3 | $1.15M | Sell |
96,600
-21,300
| -18% | -$243K | ﹤0.01% | 4131 |
|
|
2017
Q2 | $1.19M | Buy |
117,900
+47,500
| +67% | +$532K | ﹤0.01% | 3849 |
|
|
2017
Q1 | $820K | Buy |
+70,400
| New | +$505K | ﹤0.01% | 4288 |
|
|
2016
Q4 | – | Sell |
-13,400
| Closed | -$104K | – | 7829 |
|
|
2016
Q3 | $104K | Buy |
+13,400
| New | +$86.2K | ﹤0.01% | 6640 |
|
|
2016
Q2 | – | Sell |
-17,400
| Closed | -$148K | – | 7398 |
|
|
2016
Q1 | $148K | Buy |
17,400
+1,400
| +9% | +$12.3K | ﹤0.01% | 5838 |
|
|
2015
Q4 | $191K | Buy |
16,000
+9,700
| +154% | +$123K | ﹤0.01% | 5860 |
|
|
2015
Q3 | $64K | Sell |
6,300
-14,200
| -69% | -$212K | ﹤0.01% | 7397 |
|
|
2015
Q2 | $340K | Buy |
20,500
+400
| +2% | +$6.33K | ﹤0.01% | 5576 |
|
|
2015
Q1 | $311K | Sell |
20,100
-15,700
| -44% | -$238K | ﹤0.01% | 5599 |
|
|
2014
Q4 | $567K | Sell |
35,800
-18,900
| -35% | -$246K | ﹤0.01% | 4548 |
|
|
2014
Q3 | $584K | Buy |
54,700
+10,100
| +23% | +$93.7K | ﹤0.01% | 4410 |
|
|
2014
Q2 | $419K | Buy |
44,600
+42,800
| +2,378% | +$274K | ﹤0.01% | 4629 |
|
|
2014
Q1 | $12K | Sell |
1,800
-900
| -33% | -$5.33K | ﹤0.01% | 7466 |
|
|
2013
Q4 | $11K | Buy |
+2,700
| New | +$10.9K | ﹤0.01% | 6688 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Citadel Advisors's TGTX Position: Q1 2026 in Review
Citadel Advisors increased its TG Therapeutics (TGTX) stake by 90% in Q1 2026, buying an estimated $27.2M and bringing the position to 1,922,889 shares worth $63.9M. The position accounts for 0.01% of the portfolio, ranked #1140.
Citadel Advisors first reported a position in TGTX in Q4 2013 and has held it in 48 quarters since. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Citadel Advisors held 1,922,889 shares of TG Therapeutics worth $63.9M as of Q1 2026.
- Citadel Advisors bought 911,852 TG Therapeutics shares in Q1 2026, an estimated $27.2M.
- TG Therapeutics made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1140 holding.
- Citadel Advisors first reported a position in TG Therapeutics in Q4 2013 and has held it in 48 quarters since.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.